We are live on ! Find out more
S

SignatureFD Portfolio holdings

AUM $7.49B
1-Year Est. Return 24.82%
This Fund
S&P 500
This Quarter Est. Return
+6.35%
1 Year Est. Return
+24.82%
3 Year Est. Return
+73.56%
5 Year Est. Return
+79.97%
10 Year Est. Return
+256.52%
AUM
$3.92B
AUM Growth
+$253M
Cap. Flow
+$56.1M
Cap. Flow %
1.43%
Top 10 Hldgs %
56.53%
Holding
3,431
New
156
Increased
1,388
Reduced
1,134
Closed
204

Sector Composition

Rank Sector Weight
1 Technology 7.52%
2 Consumer Discretionary 3.94%
3 Financials 3.64%
4 Healthcare 3.41%
5 Industrials 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REPL icon
2876
Replimune Group
REPL
$454M
$1.53K ﹤0.01%
66
+26
+65% +$508
DXPE icon
2877
DXP Enterprises
DXPE
$2.3B
$1.53K ﹤0.01%
42
COLL icon
2878
Collegium Pharmaceutical
COLL
$1.18B
$1.53K ﹤0.01%
71
-13
-15% -$295
SWTX
2879
DELISTED
SpringWorks Therapeutics
SWTX
$1.52K ﹤0.01%
58
+30
+107% +$788
IWL icon
2880
iShares Russell Top 200 ETF
IWL
$2.13B
$1.49K ﹤0.01%
+14
New +$1.41K
CYD icon
2881
China Yuchai International
CYD
$1.69B
$1.49K ﹤0.01%
+142
New +$1.2K
OPLN
2882
Openlane
OPLN
$4.28B
$1.48K ﹤0.01%
97
+18
+23% +$262
ADEA icon
2883
Adeia
ADEA
$2.55B
$1.48K ﹤0.01%
134
-188
-58% -$1.72K
BRY
2884
DELISTED
Berry Corp
BRY
$1.47K ﹤0.01%
214
-1,147
-84% -$8.27K
PROK icon
2885
ProKidney
PROK
$316M
$1.46K ﹤0.01%
130
+25
+24% +$266
SRI icon
2886
Stoneridge
SRI
$200M
$1.45K ﹤0.01%
77
-30
-28% -$526
VIR icon
2887
Vir Biotechnology
VIR
$1.46B
$1.45K ﹤0.01%
59
-1,241
-95% -$31.2K
SCHL icon
2888
Scholastic
SCHL
$774M
$1.44K ﹤0.01%
37
+25
+208% +$970
WMG icon
2889
Warner Music
WMG
$15.2B
$1.44K ﹤0.01%
55
ASIX icon
2890
AdvanSix
ASIX
$542M
$1.43K ﹤0.01%
41
-124
-75% -$4.5K
IHE icon
2891
iShares US Pharmaceuticals ETF
IHE
$1.49B
$1.43K ﹤0.01%
24
+6
+33% +$357
ANIK icon
2892
Anika Therapeutics
ANIK
$215M
$1.43K ﹤0.01%
55
HLGN
2893
DELISTED
Heliogen, Inc.
HLGN
$1.43K ﹤0.01%
166
PAGP icon
2894
Plains GP Holdings
PAGP
$5.28B
$1.42K ﹤0.01%
96
+2
+2% +$28
CPRX
2895
DELISTED
Catalyst Pharmaceutical
CPRX
$1.41K ﹤0.01%
105
EPAC icon
2896
Enerpac Tool Group
EPAC
$1.86B
$1.4K ﹤0.01%
52
-6
-10% -$152
FIZZ icon
2897
National Beverage
FIZZ
$3.06B
$1.4K ﹤0.01%
29
-4
-12% -$201
NAPA
2898
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$1.4K ﹤0.01%
108
-75
-41% -$1.06K
FUSN
2899
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$1.4K ﹤0.01%
300
WKHS icon
2900
Workhorse Group
WKHS
$33.4M
$1.4K ﹤0.01%
1

Similar funds

SignatureFD's Q2 2023 Portfolio in Review

As of Q2 2023, SignatureFD held 3,431 positions worth $3.92B, up 6.9% from $3.66B the previous quarter. Its ten largest holdings account for 57% of the portfolio.

SignatureFD's Q2 2023 filing shows 156 new, 1,388 increased, 1,134 reduced and 204 closed positions. Its largest new stake was Oxford Lane Capital: 8,000 shares worth $194K. The largest sale was JPMorgan Ultra-Short Income ETF, an estimated $3.85M.

By sector, the portfolio is most concentrated in Technology at 7.5% of assets, up from 6.9% a quarter earlier, followed by Consumer Discretionary and Financials.

  • SignatureFD's largest Q2 2023 buy was Oxford Lane Capital: 8,000 shares worth $194K.
  • SignatureFD added most to Vanguard FTSE Emerging Markets ETF in Q2 2023, an estimated $12.5M increase.
  • SignatureFD's biggest Q2 2023 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $3.85M.
  • SignatureFD fully exited ABB Ltd in Q2 2023, selling an estimated $1.31M.
  • SignatureFD's ten largest holdings make up 57% of its $3.92B portfolio in Q2 2023.
  • SignatureFD opened 156 new positions and closed 204 in Q2 2023.
  • SignatureFD's portfolio value rose 6.9% quarter-over-quarter to $3.92B.

Based on SignatureFD's 13F filing for Q2 2023, filed 1 Aug 2023.